CHOPS Study Reveals Proton Therapy Show Efficacy & Low Risk with Children Battling High-Risk NeuroBlastoma

NeuroBlastoma TrialsiteN

Children’s Hospital of Philadelphia researchers analyzed the largest cohort data to date of pediatric patients with high-risk neuroblastoma treated with proton radiation therapy (PRT), finding both that proton therapy was effective at reducing tumors and demonstrated minimal toxicity to surrounding organs.

Lead Research/Investigator

Christine Hill-Kayser, MD, Chief of the Pediatric Radiation Oncology Service